| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Meng An CEO | XFRA Exchange | KYG2524A1031 ISIN |
| China Country | 3,178 Employees | 9 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Consun Pharmaceutical Group Limited is an investment holding company focused on the research, development, manufacturing, and sales of Chinese medicines and medical contrast medium products primarily within the People's Republic of China. Operating through its two subdivisions, Consun Pharmaceutical and Yulin Pharmaceutical, the company has established a significant presence in the Chinese pharmaceutical industry since its inception in 1997. With its headquarters based in Guangzhou, Consun Pharmaceutical Group is dedicated to addressing a variety of health conditions through its comprehensive range of products.